Navigation Links
Stanford Professor Barry M. Trost Visits WuXi PharmaTech and Gives Two Seminars
Date:5/21/2008

SHANGHAI, China, May 21 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, is proud to announce that the distinguished Stanford University Professor Barry M. Trost ( http://www.stanford.edu/group/bmtrost/ ) has visited WuXi PharmaTech and given two seminars on May 19 and 20.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

Dr. Barry M. Trost, Tamaki Professor of Humanities and Sciences in the chemistry department at Stanford University, is a world renowned organic chemist and a fellow of the U.S. National Academy of Sciences. Professor Barry M. Trost's professional interests include asymmetric allylic alkylation and efficient enantioselective synthesis. He has made great contributions to the modern synthetic organic chemistry and green chemistry. Many widely used chemistry reactions, such as the Trost asymmetric allylic alkylation, Tsuji-Trost reaction and the Trost ligand, are named after him.

Professor Trost studied at the University of Pennsylvania and received his Ph.D. from the Massachusetts Institute of Technology in 1965. He was a professor at the University of Wisconsin-Madison from 1965 until his appointment to Stanford University in 1987. Professor Trost has more than 820 scientific publications, over 320 lectures at various national and international meetings, and over 40 worldwide awards and honors.

As another luminary speaker of WuXi PharmaTech Science Seminar Series, Professor Trost gave the WuXi scientists two lectures titled "New Synthetic Strategies to Bioactive Products" and "On Inventing Reactions for Atom Economy." Professor Trost captivated the audience from beginning to end during the lectures and answered questions from the packed crowd.

"This is my first time to give a lecture to a pharmaceutical service company in China. I am very impressed by WuXi's Science Seminar Series program as well as the research capability and scientific acumen of WuXi's young scientists. Talents are absolutely the key to success for any business, especially for WuXi which provides high quality research and development services to global life science companies," commented Professor Barry M. Trost.

"We are very privileged to have Dr. Trost share his brilliant expertise with our young scientists," commented Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech. "As we broaden our R&D service scope our success very much depends on the quality of our scientists. Investing in people is and will continue to be one of our top strategies."

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. For more information, please visit: http://www.wuxipharmatech.com .

For more information, please contact:

Sherry Shao

Tel: +86-21-5046-4002

Email: pr@pharmatechs.com


'/>"/>
SOURCE WuXi PharmaTech
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Vital Images Showcases the ViTAL Enterprise Solution at Stanford Universitys 6th Annual Face-Off
2. Brooks Brothers CEO at St. Jude Childrens Research Hospital(R) To Announce Partnership With Stanford St. Jude Championship
3. Stanford researchers synthesize compound to flush HIV out of hiding
4. High blood pressure still sneaking past doctors, Stanford study shows
5. Inaugural Stanford International Pro-Am Winner A Remarkable Story in Determination And the Powerful Impact of St. Jude Childrens Research Hospital
6. Defending Champion Woody Austin Helps Memphis Kick-off Countdown to 2008 Stanford St. Jude Championship
7. Stanford University School of Medicine to Address Improving Network Security and Management at EDUCAUSE Western Regional Conference 2008 Using Lancopes StealthWatch System for Network Behavior Analysis
8. YoNaturals to Install Healthy Vending Machines at Stanford University
9. Stanford researchers unmask proteins in telomerase, a substance that enables cancer
10. Cancer detected earlier, faster, with new medical imaging, Stanford study finds
11. Stanford biologist awarded 2008 Sophie Prize in Norway
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 2017 , ... Lori R. Somekh, founder of the Law Office of ... elder law and special needs planning attorneys. “Membership in ElderCounsel helps our office remain ... to network with elder law attorneys nationwide,” said Somekh. , ElderCounsel ...
(Date:10/13/2017)... N.J. (PRWEB) , ... October 13, 2017 , ... The ... Holly Day Market. Featuring a collection of specialty vendors and unique items from across ... personalized and quality-focused health and wellness services offered by the VNA. The boutique ...
(Date:10/13/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has ... least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a ... centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “The Journey: ... faced every danger possible to save lost souls in the Philippines. “The Journey: From ... Carole is a dedicated teacher of the Bible. She has taught all ages and ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/19/2017)... 2017   ZirMed Inc ., a recognized leader in ... it has been ranked #1 by its users for the ... 2017 User Survey. ZirMed was recognized as the top-ranked end-to-end ... medical centers over 200 beds and holds one of the ... survey history. ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis , ... supply chains, has published the first annual edition of its Global CSR ... than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed ... ... & Performance Index ...
Breaking Medicine Technology: